News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials
Nico Gagelmann/X
Apr 13, 2024, 11:41

Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials

Nico Gagelmann, shared on their X/Twitter:

”Finally out. Methodological challenges in the development of endpoints for myelofibrosis clinical trials.”

Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials

Proceed to the article.
Source: Nico Gagelmann/X

cancer clinical research clinical trials drug development EBMT European Society for Blood and Marrow Transplantation Medical Research Methodological Challenges myelofibrosis Nico Gagelmann OncoDaily Oncology
Special Coverage
Blog
Mar 26, 2025, 06:31
Yelak Biru: First relapse in multiple myeloma - the patient perspective
Blog
Mar 26, 2025, 06:30
Beyond the Cancer Diagnosis: Dialogue with Nina Linchiki, by Adrian Pogacian
Blog
Mar 26, 2025, 06:10
Sumanta K. Pal: Neoantigen generation in kidney cancer
Blog
Mar 26, 2025, 04:40
Wei Zhang: We will keep our foot on the gas
Blog
Mar 26, 2025, 03:22
Angus Pratt was awarded The King Charles III Coronation medal
Oncolibrary
Mar 26, 2025, 02:43
New Paper Alert: Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial):
Blog
Mar 26, 2025, 01:41
Inside MaTOS GU25: Insights from Chandler Park part 2
Blog
Mar 26, 2025, 01:17
Adam Weiner: Transperineal biopsy versus transrectal prostate biopsy
Blog
Mar 26, 2025, 00:28
MYC in cancer: from undruggable target to clinical trials
Blog
Mar 25, 2025, 20:07
Diego A. Díaz García: cfDNA fragmentomics is redefining cancer detection
Opinion
Mar 25, 2025, 19:51
Sachin Jain on the challenges of data literacy, AI, and medicine’s uncomfortable relationship with math
Blog
Mar 25, 2025, 19:50
Hidehito Horinouchi: Amivantamab plus Lazertinib vs. Osimertinib in 1L EGFRm Advanced NSCLC